We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELP
3051
DELISTED
Cypress Environmental Partners, L.P.
CELP
$194K ﹤0.01%
32,400
+18,900
+140% +$130K
CVU icon
3052
CPI Aerostructures
CVU
$68.5M
$193K ﹤0.01%
21,600
-1,000
-4% -$8.98K
MN
3053
DELISTED
MANNING & NAPIER, INC.
MN
$193K ﹤0.01%
53,500
-8,300
-13% -$31.2K
EDD
3054
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
$192K ﹤0.01%
24,973
-945
-4% -$7.38K
APD icon
3055
CALL
Air Products & Chemicals
APD
$67.6B
$191K ﹤0.01%
61,500
+19,900
+48% +$3.17M
PCN
3056
PIMCO Corporate & Income Strategy Fund
PCN
$885M
$191K ﹤0.01%
11,113
+416
+4% +$7.06K
GTN icon
3057
Gray Television
GTN
$552M
$190K ﹤0.01%
11,362
-1,601
-12% -$25K
SA
3058
Seabridge Gold
SA
$3.35B
$190K ﹤0.01%
16,820
-200
-1% -$2.37K
KIO
3059
KKR Income Opportunities Fund
KIO
$457M
$189K ﹤0.01%
+11,767
New +$194K
KPTI icon
3060
Karyopharm Therapeutics
KPTI
$48M
$189K ﹤0.01%
1,316
+116
+10% +$18.6K
PIR
3061
DELISTED
Pier 1 Imports, Inc.
PIR
$189K ﹤0.01%
2,285
-29
-1% -$2.58K
CVE icon
3062
Cenovus Energy
CVE
$52.1B
$188K ﹤0.01%
20,578
+206
+1% +$2K
FMY
3063
First Trust Mortgage Income Fund
FMY
$48.7M
$188K ﹤0.01%
13,143
+775
+6% +$11K
WNEB icon
3064
Western New England Bancorp
WNEB
$275M
$186K ﹤0.01%
17,055
DBE icon
3065
Invesco DB Energy Fund
DBE
$85.3M
$185K ﹤0.01%
+12,733
New +$175K
NWBI icon
3066
Northwest Bancshares
NWBI
$2.28B
$184K ﹤0.01%
+10,990
New +$185K
PCM
3067
PCM Fund
PCM
$70.1M
$183K ﹤0.01%
15,774
FHY
3068
DELISTED
First Trust Strategic High
FHY
$182K ﹤0.01%
14,142
+1,455
+11% +$19K
MNE
3069
DELISTED
Blackrock MUNI New York Intermediate Duration Fund, Inc.
MNE
$182K ﹤0.01%
13,375
+3,030
+29% +$41.6K
MFT
3070
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
$182K ﹤0.01%
13,056
+1,256
+11% +$17.8K
EHI
3071
Western Asset Global High Income Fund
EHI
$178M
$181K ﹤0.01%
17,722
-1,269
-7% -$12.8K
AFB
3072
AllianceBernstein National Municipal Income Fund
AFB
$317M
$180K ﹤0.01%
13,421
-10,726
-44% -$147K
EVH icon
3073
Evolent Health
EVH
$447M
$180K ﹤0.01%
14,599
+17
+0.1% +$240
VTLE
3074
DELISTED
Vital Energy
VTLE
$180K ﹤0.01%
848
-510
-38% -$112K
VUZI icon
3075
Vuzix
VUZI
$224M
$179K ﹤0.01%
+28,615
New +$166K

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.